Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Gains from Investment Securities (2022 - 2025)

Praxis Precision Medicines has reported Gains from Investment Securities over the past 4 years, most recently at -$1.3 million for Q4 2025.

  • Quarterly results put Gains from Investment Securities at -$1.3 million for Q4 2025, down 736.42% from a year ago — trailing twelve months through Dec 2025 was $7000.0 (changed N/A YoY), and the annual figure for FY2025 was $7000.0, changed.
  • Gains from Investment Securities for Q4 2025 was -$1.3 million at Praxis Precision Medicines, down from $52000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for PRAX hit a ceiling of $1.2 million in Q1 2025 and a floor of -$1.3 million in Q4 2025.
  • Median Gains from Investment Securities over the past 4 years was $10000.0 (2022), compared with a mean of $16687.5.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 1985.71% in 2023 and later soared 5100.0% in 2025.
  • Praxis Precision Medicines' Gains from Investment Securities stood at $7000.0 in 2022, then plummeted by 1985.71% to -$132000.0 in 2023, then dropped by 14.39% to -$151000.0 in 2024, then crashed by 736.42% to -$1.3 million in 2025.
  • The last three reported values for Gains from Investment Securities were -$1.3 million (Q4 2025), $52000.0 (Q3 2025), and $23000.0 (Q2 2025) per Business Quant data.